VYNE Therapeutics Inc (VYNE) News
Follow VYNE Therapeutics Inc (VYNE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Why Crown Holdings Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Crown Holdings Inc (NYSE: CCK ) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and raised its FY26 adjusted EPS guidance above estimates. Cro
EARNINGS | Jul 21, 2026, 09:11 AM UTC
H
VYNE Therapeutics Declares Estimated $0.38-Per-Share Special Cash Dividend Ahead of Yarrow Merger
() -- VYNE Therapeutics (VYNE) on Friday declared a special cash dividend estimated at $16.5 million, or about $0.38 per share, in connection with its pending merger with Yarrow Bioscience. The dividend will be payable t
MNA | Jul 10, 2026, 12:33 PM UTC
H
VYNE Therapeutics declares special cash dividend with Yarrow Bioscience merger
VYNE Therapeutics announced that its board of directors has declared a special cash dividend in connection with the previously announced merger with Yarrow Bioscience, pursuant to the agreement and plan of merger and reo
EQUITY | Jul 10, 2026, 12:08 PM UTC